Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Targeting Long Noncoding Rnas in Neuroblastoma: Progress and Prospects Publisher Pubmed



Ataei A1 ; Tahsili M2 ; Hayadokht G3 ; Daneshvar M4 ; Mohammadinour S5 ; Soofi A6 ; Masoudi A7 ; Kabiri M8 ; Natami M9
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Bam University of Medical Sciences, Bam, Iran
  2. 2. Payam Nour University of Taft, Yazd, Iran
  3. 3. School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
  4. 4. Tehran University of Medical Sciences, Tehran, Iran
  5. 5. School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran
  6. 6. Department of Physical Chemistry, School of Chemistry, College of Sciences, University of Tehran, Tehran, Iran
  7. 7. Department of Laboratory Sciences, Faculty of Alied Medical Sciences, Qom University of Medical Sciences, Qom, Iran
  8. 8. Faculty of Medicine, Islamic Azad University of Medical Sciences, Tehran, Iran
  9. 9. Department of Urology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Chemical Biology and Drug Design Published:2023


Abstract

Neuroblastoma (NB) is the third most prevalent tumor that mostly influences infants and young children. Although different treatments have been developed for the treatment of NB, high-risk patients have been reported to have low survival rates. Currently, long noncoding RNAs (lncRNAs) have shown an attractive potential in cancer research and a party of investigations have been performed to understand mechanisms underlying tumor development through lncRNA dysregulation. Researchers have just newly initiated to exhibit the involvement of lncRNAs in NB pathogenesis. In this review article, we tried to clarify the point we stand with respect to the involvement of lncRNAs in NB. Moreover, implications for the pathologic roles of lncRNAs in the development of NB have been discussed. It seems that some of these lncRNAs have promising potential to be applied as biomarkers for NB prognosis and treatment. © 2023 John Wiley & Sons Ltd.
Other Related Docs
14. The Emerging Role of Lncrnas in Multiple Sclerosis, Journal of Neuroimmunology (2020)
18. Targeting Epigenetics in Cancer: Therapeutic Potential of Flavonoids, Critical Reviews in Food Science and Nutrition (2021)
24. Lncrnas Roles in Chemoresistance of Cancer Cells, Current Molecular Medicine (2022)
25. Dysregulated Expression of Long Intergenic Non-Coding Rnas (Lincrnas) in Urothelial Bladder Carcinoma, International Journal of Molecular and Cellular Medicine (2017)
28. Modulation of Cancer Cell Signaling by Long Noncoding Rnas, Journal of Cellular Biochemistry (2019)
30. The Role of Ketogenic Diet in the Treatment of Neuroblastoma, Integrative Cancer Therapies (2023)
41. Advances in Pharmacotherapy for Neuroblastoma, Expert Opinion on Pharmacotherapy (2021)
42. Long Noncoding Rnas Biomarker-Based Cancer Assessment, Journal of Cellular Physiology (2019)
48. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)